Increasing patient comfort by optimized postoperative administration of intravesical mitomycin C

BJU International

Volumn 102, Issue 11, 2008, Pages 1556-1559

  Stoehr, Brigitte ^a   Mueller, Tilko ^a   Granig, Thomas ^a   Zangerl, Florian ^a   Steiner, Hannes ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Intravesical chemotherapy; Mitomycin C; Superficial bladder cancer

Indexed keywords

MITO EXTRA; MITOMYCIN C; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLADDER CANCER; BLADDER CONTRACTION; BLADDER DISCOMFORT; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CONTROLLED STUDY; CYSTALGIA; DEVICE; DRUG EFFECT; DRUG INSTILLATION; DRUG RESPONSE; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; URINARY CATHETER; URINE BAG;

ADMINISTRATION, INTRAVESICAL; ADULT; AGED; AGED, 80 AND OVER; ANTIBIOTICS, ANTINEOPLASTIC; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; MALE; MIDDLE AGED; MITOMYCIN; NEOPLASM RECURRENCE, LOCAL; PAIN; POSTOPERATIVE CARE; PROSPECTIVE STUDIES; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 56649085434     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2008.07898.x     Document Type: Article

References (9)

1. Sylvester RJ, Oosterlinck W, van der Meijden AP. A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials. J Urol 2004 171 : 2186 90
2. Oosterlinck W, Lobel B, Jakse G, Malmstrom PU, Stockle M, Sternberg C. Guidelines on bladder cancer. Eur Urol 2002 41 : 105 12
3. Wientjes MG, Badalament RA, Wang RC, Hassan F, Au JL. Penetration of mitomycin C in human bladder. Cancer Res 1993 53 : 3314 20
4. Thrasher JB, Crawford ED. Complications of intravesical chemotherapy. Urol Clin North Am 1992 19 : 529 39
5. Nieuwenhuijzen JA, Bex A, Horenblas S. Unusual complication after immediate postoperative intravesical mitomycin C instillation. Eur Urol 2003 43 : 711 2
6. Racioppi M, Porreca A, Foschi N, Delicato G, Destito A, D'Addessi A. Bladder perforation: a potential risk of early endovesical chemotherapy with mitomycin C. Urol Int 2005 75 : 373 5
7. Barghi MR, Rahmani MR, Hosseini Moghaddam SM, Jahanbin M. Immediate intravesical instillation of mitomycin C after transurethral resection of bladder tumor in patients with low-risk superficial transitional cell carcinoma of bladder. Urol J 2006 3 : 220 4
8. De Bruijn EA, Sleeboom HP, van Helsdingen PJ, van Oosterom AT, Tjaden UR, Maes RA. Pharmacodynamics and pharmacokinetics of intravesical mitomycin C upon different dwelling times. Int J Cancer 1992 51 : 359 64
9. Lambert EH, Pierorazio PM, Olsson CA, Benson MC, McKiernan JM, Poon S. The increasing use of intravesical therapies for stage T1 bladder cancer coincides with decreasing survival after cystectomy. BJU Int 2007 100 : 33 6